IL12A and hydrops fetalis: Since IL-12α KO has no detectable detrimental effects on mouse development, cardiac structure and function, blocking IL-12α signaling may be a potentially useful therapeutic approach in treating systolic overload-induced cardiac inflammation and HF development.